131 related articles for article (PubMed ID: 36505021)
41. Prostate specific antigen cannot distinguish stage T1a (A1) prostate cancer from benign prostatic hyperplasia.
Monda JM; Barry MJ; Oesterling JE
J Urol; 1994 May; 151(5):1291-5. PubMed ID: 7512660
[TBL] [Abstract][Full Text] [Related]
42. Primary extramedullary leukemia of the prostate: case report and review of the literature.
Quien ET; Wallach B; Sandhaus L; Kidd P; Strair R; Saidi P
Am J Hematol; 1996 Dec; 53(4):267-71. PubMed ID: 8948669
[TBL] [Abstract][Full Text] [Related]
43. Urinary retention due to prostatic involvement in testicular lymphoma: a case report.
Parziani S; Rosi P; Sidoni A; Porena M
Acta Urol Belg; 1993 Sep; 61(3):33-7. PubMed ID: 8256685
[TBL] [Abstract][Full Text] [Related]
44. Response to daily 10 mg alfuzosin predicts acute urinary retention and benign prostatic hyperplasia related surgery in men with lower urinary tract symptoms.
Emberton M; Lukacs B; Matzkin H; Alcaraz A; Elhilali M; Vallancien G
J Urol; 2006 Sep; 176(3):1051-6. PubMed ID: 16890690
[TBL] [Abstract][Full Text] [Related]
45. Prostate cancer detection in candidates for open prostatectomy.
Fowler JE; Bigler SA; Kolski JM
J Urol; 1998 Dec; 160(6 Pt 1):2107-10. PubMed ID: 9817333
[TBL] [Abstract][Full Text] [Related]
46. Primary diffuse large B-cell lymphoma of the prostate: A report of two cases with diagnostic considerations.
Kakkar A; Rajeshwari M; Bhethanabhotla S; Kaur K; Jain D; Gogia A; Ray R; Seth A
J Cancer Res Ther; 2015; 11(4):977-9. PubMed ID: 26881561
[TBL] [Abstract][Full Text] [Related]
47. High rates of prostate-specific antigen testing in men with evidence of benign prostatic hyperplasia.
Meigs JB; Barry MJ; Giovannucci E; Rimm EB; Stampfer MJ; Kawachi I
Am J Med; 1998 Jun; 104(6):517-25. PubMed ID: 9674713
[TBL] [Abstract][Full Text] [Related]
48. [Malignant lymphoma of the prostate--diagnosis on the second biopsy].
Vetsch G; Baumann CK; Kläy M; Leupin N; Rentsch C; Mueller-Garamvölgyi E; Bürgi U; Schiemann U
Med Klin (Munich); 2008 Apr; 103(4):245-8. PubMed ID: 18484209
[TBL] [Abstract][Full Text] [Related]
49. Permanent interstitial brachytherapy for prostate cancer implementing neoadjuvant prostatic artery embolization.
Haddad H; Hermani H; Bischoff P; Hanitzsch H; Heidrich A; Schaefer A; Kovács A; Pinkawa M
Brachytherapy; 2022; 21(3):308-316. PubMed ID: 35123887
[TBL] [Abstract][Full Text] [Related]
50. Detection of prostate cancer and changes in prostate-specific antigen (PSA) six months after surgery for benign prostatic hyperplasia in patients with elevated PSA.
Ozden C; Inal G; Adsan O; Yazici S; Ozturk B; Cetinkaya M
Urol Int; 2003; 71(2):150-3. PubMed ID: 12890951
[TBL] [Abstract][Full Text] [Related]
51. Clinical, laboratorial, and urodynamic findings of prostatic artery embolization for the treatment of urinary retention related to benign prostatic hyperplasia. A prospective single-center pilot study.
Antunes AA; Carnevale FC; da Motta Leal Filho JM; Yoshinaga EM; Cerri LM; Baroni RH; Marcelino AS; Cerri GG; Srougi M
Cardiovasc Intervent Radiol; 2013 Aug; 36(4):978-86. PubMed ID: 23580116
[TBL] [Abstract][Full Text] [Related]
52. Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate.
Terk MD; Stock RG; Stone NN
J Urol; 1998 Oct; 160(4):1379-82. PubMed ID: 9751358
[TBL] [Abstract][Full Text] [Related]
53. Incidental and concurrent malignant lymphomas discovered at the time of prostatectomy and prostate biopsy: a study of 29 cases.
Chu PG; Huang Q; Weiss LM
Am J Surg Pathol; 2005 May; 29(5):693-9. PubMed ID: 15832096
[TBL] [Abstract][Full Text] [Related]
54. Clinical progression, acute urinary retention, prostate-related surgeries, and costs in patients with benign prostatic hyperplasia taking early versus delayed combination 5α-reductase inhibitor therapy and α-blocker therapy: a retrospective analysis.
Morlock R; Goodwin B; Gomez Rey G; Eaddy M
Clin Ther; 2013 May; 35(5):624-33. PubMed ID: 23583026
[TBL] [Abstract][Full Text] [Related]
55. Enhanced expression of prostate-specific antigen in the transition zone of the prostate. A characterization following prostatectomy for benign hyperplasia.
Recker F; Kwiatkowski MK; Pettersson K; Piironen T; Lümmen G; Huber A; Tscholl R
Eur Urol; 1998; 33(6):549-55. PubMed ID: 9743696
[TBL] [Abstract][Full Text] [Related]
56. Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. PLESS Study Group.
Roehrborn CG; McConnell JD; Lieber M; Kaplan S; Geller J; Malek GH; Castellanos R; Coffield S; Saltzman B; Resnick M; Cook TJ; Waldstreicher J
Urology; 1999 Mar; 53(3):473-80. PubMed ID: 10096369
[TBL] [Abstract][Full Text] [Related]
57. Primary diffuse large B-Cell lymphoma of the prostate presenting with urinary retention and dyschezia for which rituximab-combined CHOP therapy was effective-a case presentation.
Manabe M; Hayashi Y; Yoshii Y; Mukai S; Sakamoto E; Kanashima H; Nakao T; Hayama T; Fukushima H; Inoue T; Yamane T; Teshima H
Gan To Kagaku Ryoho; 2012 Nov; 39(11):1733-5. PubMed ID: 23152030
[TBL] [Abstract][Full Text] [Related]
58. Intravascular large B cell lymphoma of prostate, a rare entity.
Rallabandi HB; Thirukovela J; Swain M; Meeramira D; Gowrishankar S
Indian J Pathol Microbiol; 2021; 64(3):575-578. PubMed ID: 34341277
[TBL] [Abstract][Full Text] [Related]
59. Prospective study of the role of transurethral resection of the prostate in patients with an elevated prostate-specific antigen level, minor lower urinary tract symptoms, and proven bladder outlet obstruction.
van Renterghem K; Van Koeveringe G; Achten R; van Kerrebroeck P
Eur Urol; 2008 Dec; 54(6):1385-92. PubMed ID: 18599187
[TBL] [Abstract][Full Text] [Related]
60. Mesonephric remnant hyperplasia involving prostate and periprostatic tissue: findings at radical prostatectomy.
Chen YB; Fine SW; Epstein JI
Am J Surg Pathol; 2011 Jul; 35(7):1054-61. PubMed ID: 21606823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
